Comment in 2018

Filter By:

Article Type
Year
  • Promising immunizations for diseases that affect mostly people in low- and middle-income countries need help getting to market, urge David C. Kaslow and colleagues.

    • David C. Kaslow
    • Steve Black
    • Rino Rappuoli
    Comment
  • With sources of renewable energy spreading fast, all sectors can do more to decarbonize the world, argue Christiana Figueres and colleagues.

    • Christiana Figueres
    • Corinne Le Quéré
    • Dabo Guan
    Comment
  • Misleading terminology and arbitrary divisions stymie drug trials and can give false hope about the potential of tailoring drugs to individuals, warns Stephen Senn.

    • Stephen Senn
    Comment
  • Bitcoin and other cryptocurrencies will founder unless they integrate quantum technologies, warn Aleksey K. Fedorov, Evgeniy O. Kiktenko and Alexander I. Lvovsky.

    • Aleksey K. Fedorov
    • Evgeniy O. Kiktenko
    • Alexander I. Lvovsky
    Comment
  • Access to evidence from disappointing drug-development programmes advances the whole scientific process, explain Enrica Alteri and Lorenzo Guizzaro.

    • Enrica Alteri
    • Lorenzo Guizzaro
    Comment
  • Global conservation policy must stop the disappearance of Earth’s few intact ecosystems, warn James E. M. Watson, James R. Allan and colleagues.

    • James E. M. Watson
    • Oscar Venter
    • James R. Allan
    Comment
  • Governments should use patents to shape the deployment of CRISPR–Cas9 as they have done for past technologies, argues Shobita Parthasarathy.

    • Shobita Parthasarathy
    Comment
  • Using artificial intelligence to predict outbursts of violence and probe their causes could save lives, argue Weisi Guo, Kristian Gleditsch and Alan Wilson.

    • Weisi Guo
    • Kristian Gleditsch
    • Alan Wilson
    Comment
  • Sand-grain-sized computers, self-healing materials and constellations of craft would reboot our reach, explain Igor Levchenko, Michael Keidar and colleagues.

    • Igor Levchenko
    • Michael Keidar
    • Shuyan Xu
    Comment
  • Three examples show how public participation in research can be extended at every step of the process to generate useful knowledge.

    • Gary Hickey
    • Tessa Richards
    • Jeff Sheehy
    Comment
  • To assess whether research is relevant to society, ask the stakeholders, say Catherine Durose, Liz Richardson and Beth Perry.

    • Catherine Durose
    • Liz Richardson
    • Beth Perry
    Comment
  • Confusion about mesenchymal stem cells is making it easier for people to sell unproven treatments, warn Douglas Sipp, Pamela G. Robey and Leigh Turner.

    • Douglas Sipp
    • Pamela G. Robey
    • Leigh Turner
    Comment